Such increases, however, were not observed in p21-knockout (KO) mice exposed to the same treatments, revealing that absence of p21 prior to disease onset alleviates BLM-induced development of senescent cells, inflammation, and lung fibrosis. The gene discussed is CDKN1A; the disease is pulmonary fibrosis.